4 months ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 4.3% – Should You Buy? MarketBeat

ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 4.3% – Still a Buy?

Nasdaq 100 · Pharmaceuticals